 |
Adv Healthc Mater
- YIN Y, Qin Z, Zhou H, Wu Y, et al
Ultrasound Responsive Mn/Se-Nanozyme as PANoptosis Initiators for Bladder Cancer
Immunotherapy.
Adv Healthc Mater. 2026 Feb 3:e04808. doi: 10.1002/adhm.202504808.
PubMed
Abstract available
Adv Sci (Weinh)
- KONG L, Yang G, Weng B, Wen Z, et al
Early Detection of Chemotherapy-Induced Glucose Metabolic Alterations in Bladder
Carcinoma Using Deuterium ((2)H) Metabolic Imaging: in Vitro and in Vivo
Assessments.
Adv Sci (Weinh). 2026;13:e14614.
PubMed
Abstract available
Afr Health Sci
- LIU N, Xing L, Chen H, Chen S, et al
Sequential dilatation of two balloons and double D-J stents for therapy of
ureteroenteral anastomotic stricture in patients following radical cystectomy and
Bricker urinary diversion.
Afr Health Sci. 2025;25:334-342.
PubMed
Abstract available
Am J Clin Pathol
- NABIYOUNI F, Chiou PZ
Enhancing urine cytopathology with artificial intelligence: a systematic review.
Am J Clin Pathol. 2026;165:aqaf135.
PubMed
Abstract available
Ann Surg Oncol
- LIU Q, Lu X, He C, Chen J, et al
A Novel Model for Muscle-Invasive Bladder Cancer Diagnosis Using
Contrast-Enhanced Ultrasound.
Ann Surg Oncol. 2026 Feb 4. doi: 10.1245/s10434-026-19122.
PubMed
Abstract available
- WANG Y, Guo S, Zeng J, Feng W, et al
Prognostic Significance of Lymph Node Ratio for Overall Survival in Patients with
Lymph Node-Positive Bladder Cancer Post-Radical Cystectomy and Chemotherapy: A
Multicenter Cohort Analysis.
Ann Surg Oncol. 2026 Feb 4. doi: 10.1245/s10434-026-19090.
PubMed
Abstract available
- HAJIME T, Shiota M, Matsumoto T, Mutaguchi J, et al
ASO Author Reflections: Tumor Laterality as a Key Determinant of Pelvic Lymph
Node Dissection Strategy in Bladder Cancer.
Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-026-19200.
PubMed
- MEHMUD I, Zhang Y, Wu S, Zhang S, et al
Oncological Safety of Bladder Preservation in Elderly Patients with
Muscle-Invasive Bladder Cancer.
Ann Surg Oncol. 2026 Feb 6. doi: 10.1245/s10434-025-19064.
PubMed
Abstract available
Appl Immunohistochem Mol Morphol
- HSIEH YC, Li CF, Ho CH, Huang SK, et al
Evaluation of Clinical and Prognostic Roles of CCL8 in Urinary Bladder Cancer and
Upper Tract Urothelial Carcinoma.
Appl Immunohistochem Mol Morphol. 2026 Feb 5. doi: 10.1097/PAI.0000000000001307.
PubMed
Abstract available
Asian J Endosc Surg
- MORIKAWA T, Hamamoto S, Tasaki Y, Ishikawa D, et al
Evaluation of the Safety of Robot-Assisted Radical Cystectomy for Bladder Cancer
in Octogenarians.
Asian J Endosc Surg. 2026;19:e70248.
PubMed
Abstract available
- YOKOYAMA T, Kobayashi H, Horiguchi A, Miyai K, et al
A Case of Primary Bladder Neuroendocrine Carcinoma With Urethral Invasion
Following Radical Prostatectomy.
Asian J Endosc Surg. 2026;19:e70251.
PubMed
Abstract available
Biopreserv Biobank
- MOJICA W, Izydorczak A, Wood T, Hsu J, et al
A Novel Method to Generate Analyte-Specific Specimens for Multi-Omic Studies of
Primary Bladder Cancer.
Biopreserv Biobank. 2026 Feb 6:19475535251394594. doi: 10.1177/19475535251394594
PubMed
Abstract available
BMC Cancer
- OSAKA K, Kishida T, Umemoto S, Karashima T, et al
Evaluation of variations in urine laminin-gamma2 monomer in non-muscle-invasive
bladder cancer before and after transurethral resection of the bladder tumor.
BMC Cancer. 2026 Feb 2. doi: 10.1186/s12885-026-15658.
PubMed
- ISKENDER B, Sarihan M, Barlak BSR, Akpinar G, et al
Conjoining cell reprogramming and mass spectrometry to identify the proteomic
variations in the reprogrammed bladder cancer cells: finding cues of
normalisation.
BMC Cancer. 2026 Feb 6. doi: 10.1186/s12885-026-15634.
PubMed
BMJ Oncol
- SOMA T, Takemura K, Toide M, Ito M, et al
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus
Calmette-Guerin failure: a systematic review.
BMJ Oncol. 2026;5:e000753.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
- BOURGI A, Rusch E, Bruyere F
Water-Related Exposures And Bladder Cancer Risk: A Comprehensive Epidemiological
Review.
Cancer Epidemiol Biomarkers Prev. 2026.
PubMed
Abstract available
Cancer Invest
- WANG J, Zhao X, Jiang XL, Liu G, et al
Construction and Validation of a Prognostic Survival Prediction Model for NMIBC
Patients Undergoing Radical Cystectomy.
Cancer Invest. 2026;44:156-173.
PubMed
Abstract available
Cancer Lett
- YU K, Sun J, Zhang J, Shi Y, et al
Lactylation enhances YTHDF3 stability to promote cisplatin resistance via
m6A-dependent KDM6B decay in bladder cancer.
Cancer Lett. 2026;642:218282.
PubMed
Abstract available
Cancer Metastasis Rev
- ZHOU J, Jiang X, Liu Q, Xia HA, et al
PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity
to chemotherapy: an integrated analysis of digitized trial results.
Cancer Metastasis Rev. 2026;45:7.
PubMed
Abstract available
Cell Mol Life Sci
- ZHANG H, Liu Y, Huang W, Li Y, et al
Mediator complex subunit 8 promotes bladder cancer progression via Stearoyl-CoA
desaturase.
Cell Mol Life Sci. 2026 Feb 3. doi: 10.1007/s00018-026-06083.
PubMed
Cell Rep
- XU G, Li Y, Peng S, Zhao W, et al
Delactylation of the tumor suppressor ARHGDIB drives metastasis and
chemoresistance in bladder cancer.
Cell Rep. 2026;45:116941.
PubMed
Abstract available
Cell Signal
- SONG T, He W, Yuan Q, Xia S, et al
ADAM12-programmed ECM-CAF remodeling activates PI3K-AKT and enforces an
immune-excluded microenvironment to drive bladder cancer progression and therapy
resistance.
Cell Signal. 2026 Feb 4:112398. doi: 10.1016/j.cellsig.2026.112398.
PubMed
Abstract available
Clin Cancer Res
- GUERCIO BJ, Pietzak EJ, Ravichandran V, Chen JF, et al
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible
patients with muscle-invasive bladder cancer.
Clin Cancer Res. 2026 Feb 2. doi: 10.1158/1078-0432.CCR-25-3771.
PubMed
Abstract available
Commun Biol
- KIELBIK A, Hellwich E, Bahlinger V, Sowa P, et al
Nanosecond pulsed electric fields induce cell-size-dependent selective
permeabilization of urothelial cancer cells.
Commun Biol. 2025;9:153.
PubMed
Abstract available
Comput Methods Programs Biomed
- ZHAO J, Zhao J, Huang W, Lin W, et al
Decoding metabolic reprogramming heterogeneity across bladder cancer stages using
single-cell and spatial multi-omics approaches.
Comput Methods Programs Biomed. 2026;277:109261.
PubMed
Abstract available
Curr Drug Targets
- HARLE V, Agrawal YO
Development of Novel Intravesical Formulation for Bladder Retention Targeting
Bladder Disorders.
Curr Drug Targets. 2025;26:903-920.
PubMed
Abstract available
Curr Issues Mol Biol
- AY A, Alkanli N, Atli E, Gurkan H, et al
Investigation of the Correlation Between Selected miRNAs, Proinflammatory
Cytokines, and Serum Trace Elements in Bladder Cancer Development and
Progression.
Curr Issues Mol Biol. 2025;48:53.
PubMed
Abstract available
Curr Opin Urol
- LOPEZ-BELTRAN A, Cimadamore A, Blanca A, Montironi R, et al
Sarcomatoid urothelial carcinoma: advances and challenges.
Curr Opin Urol. 2026;36:147-154.
PubMed
Abstract available
- COMPERAT E
Biomarkers and testing in pathology.
Curr Opin Urol. 2026;36:212-216.
PubMed
Abstract available
- ERTOY-BAYDAR D
Histologic subtypes of urothelial carcinoma: an update.
Curr Opin Urol. 2026;36:138-146.
PubMed
Abstract available
- REIS H, Szarvas T, Paner GP
Urachal cancer: a clinical, diagnostic, and therapeutic update.
Curr Opin Urol. 2026;36:155-160.
PubMed
Abstract available
Drugs
- RIAZ IB, Humayun MA, Khaki AR, Hussain SA, et al
Treatment Sequencing in Advanced Urothelial Cancer.
Drugs. 2026;86:203-215.
PubMed
Abstract available
Environ Sci Technol
- WANG Y, Ni H, Dong S, Shang Y, et al
Environmental Dose MEOHP Promotes Bladder Cancer Progress through Hybrid EMT
Mechanism: Based on the Adverse Outcome Pathway.
Environ Sci Technol. 2026 Feb 6. doi: 10.1021/acs.est.5c08003.
PubMed
Abstract available
Eur Rev Med Pharmacol Sci
- DE FELICE M, Tammaro M, Caterino M, Nacca V, et al
Fulminant Fournier gangrene in bladder cancer: case report and review of the
literature.
Eur Rev Med Pharmacol Sci. 2026;30:46-50.
PubMed
Abstract available
Eur Urol
- BABJUK M
Re: Durvalumab in Combination with BCG for BCG-naive, High risk,
Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised,
Open-label, Phase 3 Trial.
Eur Urol. 2026 Feb 3:S0302-2838(26)00027-8. doi: 10.1016/j.eururo.2026.
PubMed
- PICHLER R, Subiela JD, Guerrero-Ramos F
Re: Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama, et al. Durvalumab in
Combination with BCG for BCG-naive, High-risk, Non-muscle-invasive Bladder Cancer
(POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 trial. Lancet
2025;406:2
Eur Urol. 2026 Feb 4:S0302-2838(26)00054-0. doi: 10.1016/j.eururo.2026.
PubMed
- HAYNE D, Zhang AY, Thomas H, Krieger L, et al
Bacillus Calmette-Guerin Plus Mitomycin Versus Bacillus Calmette-Guerin Alone for
Bacillus Calmette-Guerin-naive Non-muscle-invasive Bladder Cancer: A Randomised
Phase 3 Trial (ANZUP 1301).
Eur Urol. 2026 Feb 2:S0302-2838(26)00015-1. doi: 10.1016/j.eururo.2026.
PubMed
Abstract available
- GABRIEL PE, Xylinas E
Re: Ding Ding, Lei Qian, Di Jin, et al. Aptamer-based Positron Emission
Tomography Imaging Allows Specific Detection of Residual Bladder Cancer: A
First-in-Human Study. Eur Urol 2026;89:93-5.
Eur Urol. 2026 Feb 3:S0302-2838(26)00030-8. doi: 10.1016/j.eururo.2026.
PubMed
- TATEO V, Basile G, Giannatempo P, de Jong JJ, et al
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant
Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive
Bladder Cancer.
Eur Urol. 2026 Feb 2:S0302-2838(26)00022-9. doi: 10.1016/j.eururo.2026.
PubMed
Abstract available
- MYERS AA, Talwar R, Duan Z, Hensley P, et al
Cost-effectiveness Analysis of Treatments for Bacillus
Calmette-Guerin-unresponsive Carcinoma in Situ of the Bladder.
Eur Urol. 2026;89:151-162.
PubMed
Abstract available
Eur Urol Focus
- PYRGIDIS N, Schulz GB, Scilipoti P, Pellegrino F, et al
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational
Match-paired Analysis.
Eur Urol Focus. 2026;12:88-95.
PubMed
Abstract available
- CHATZKEL J, Linscott J, Daniel Grass G, Li R, et al
Urothelial Cancer: Leveraging Circulating Tumor DNA To Avoid Unnecessary
Bladder-directed and Systemic Therapies.
Eur Urol Focus. 2026;12:38-40.
PubMed
Abstract available
- FILON M, Schmidt B
The Future of Novel Antibody-drug Conjugates in Localized Urothelial Cancer.
Eur Urol Focus. 2026;12:34-37.
PubMed
Abstract available
Eur Urol Oncol
- ROBBRECHT DGJ, Salhi Y, Martens JWM, Aarts MJB, et al
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic
Urothelial Cancer-A Patient Cohort Analysis.
Eur Urol Oncol. 2026;9:7-11.
PubMed
Abstract available
- TEOH JY, Bracco FM, Wong JH, Liu AQ, et al
A Novel Transurethral Robotic Platform for Performing En Bloc Resection of
Bladder Tumour: Results from the First Phase of the VIABLE Trial.
Eur Urol Oncol. 2026;9:111-115.
PubMed
Abstract available
Front Immunol
- NING W, Chang P, Zheng J, Chen W, et al
Advances in immunotherapy for bladder cancer and clinical practice of
next-generation sequencing.
Front Immunol. 2026;16:1684597.
PubMed
Abstract available
Front Mol Biosci
- ZHANG M, Lin L, Xu H, Su X, et al
A novel tumor-progressing fibroblast signature derived from single-cell RNA
sequencing enables prognostic stratification and reveals RNF11 as a functional
regulator in bladder cancer.
Front Mol Biosci. 2026;12:1722809.
PubMed
Abstract available
Int Immunopharmacol
- JIN H
Comment on "adjuvant bacillus Calmette-Gu'erin (BCG) immunotherapy versus BCG
combined with disitamab vedotin in BCG-naive high-risk non-muscle invasive
bladder cancer with HER2 expression: A real-world study".
Int Immunopharmacol. 2026;173:116312.
PubMed
Int J Hyperthermia
- MIKHAIL AS, Gurram S, Valera VA, Haemmerich D, et al
Heat-activated intravenous liposomal doxorubicin combined with mitomycin C
hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer.
Int J Hyperthermia. 2026;43:2615462.
PubMed
Abstract available
Int J Radiat Oncol Biol Phys
- MAK KS, Efstathiou JA
Tipping the Scales for Bladder Cancer: Weighing Differences in Quality of Life
After Cystectomy Versus Trimodality Therapy.
Int J Radiat Oncol Biol Phys. 2026;124:651-653.
PubMed
Int J Surg
- WANG Z, He W, Wang M, Hua M, et al
Integrated multicenter single-cell atlas of bladder cancer reveals tumor
heterogeneity associated with immunotherapy.
Int J Surg. 2026 Feb 3. doi: 10.1097/JS9.0000000000003830.
PubMed
Abstract available
Int J Urol
- ABE Y, Taoka R, Kaji A, Harada S, et al
Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of
Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched
Analysis.
Int J Urol. 2026;33:e70365.
PubMed
Abstract available
J Endourol
- MENG X, Su CY, Yang Z
Editorial Comment on: "Enhanced Artificial Intelligence in Bladder Cancer
Management: A Comparative Analysis and Optimization Study of Multiple Large
Language Models" by Li et al.
J Endourol. 2026 Feb 2:8927790251387369. doi: 10.1177/08927790251387369.
PubMed
J Exp Clin Cancer Res
- CHEN K, Su H, Pei F, Chen X, et al
KNTC1 initiates a KNTC1/E2F8/MYC positive feedback loop to facilitate
tumorigenesis and enhance chemoresistance in bladder cancer.
J Exp Clin Cancer Res. 2026 Feb 4. doi: 10.1186/s13046-026-03651.
PubMed
J Immunother Cancer
- SHEN C, Liu C, Hu D, Ge H, et al
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via
the CXCL10-CXCR3 axis in bladder cancer.
J Immunother Cancer. 2026;14:e013809.
PubMed
Abstract available
J Pharm Anal
- WANG X, Jin L, Zou X, Zhu A, et al
ERBB2 mutations promote recurrence and metastasis in non-muscle-invasive bladder
cancer via HIF-1 phosphorylation: Insights from whole exome sequencing.
J Pharm Anal. 2026;16:101519.
PubMed
Abstract available
J Surg Oncol
- MANOHARAN M, Raja Iyub MJ, Zhang Y, Prabhakar P, et al
Development of a Multivariable Machine Learning Model for the Prediction of
Postoperative Ileus After Radical Cystectomy.
J Surg Oncol. 2026;133:226-232.
PubMed
Abstract available
Mater Today Bio
- WANG Y, Yuan H, Zhang Y, Zhang Y, et al
Intravesical folate-conjugated hydroxyethyl starch micelles for pH-triggered
co-delivery of epirubicin and TLR7 agonist toward synergistic chemoimmunotherapy
of bladder cancer.
Mater Today Bio. 2026;37:102835.
PubMed
Abstract available
Medicine (Baltimore)
- JIANG M, Sun C, Wang B, Huang Q, et al
Analysis of the molecular mechanism underlying di(2-ethylhexyl) phthalate-induced
bladder carcinogenesis via network toxicology and molecular docking approaches:
An observational study.
Medicine (Baltimore). 2026;105:e47378.
PubMed
Abstract available
medRxiv
- JALAL H, Kang SK, Alarid-Escudero F, Chrysanthopoulou SA, et al
Understanding Bladder Cancer Screening Limits Through Comparative Modeling: The
Maximum Clinical Incidence Reduction (MCLIR) Methodology.
medRxiv [Preprint]. 2026 Jan 30:2026.01.27.26344939.
PubMed
Abstract available
- GALSKY MD, Izadmehr S, Yu M, Curtis SD, et al
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing
approaches for patients with muscle-invasive bladder cancer.
medRxiv [Preprint]. 2026 Jan 16:2026.01.14.26344033.
PubMed
Abstract available
Mol Cancer
- DU A, Zhou Y, Deng X, Yuan D, et al
DCLK1 drives malignant progression and chemoresistance of bladder cancer by
deubiquitinating HDAC6.
Mol Cancer. 2026 Jan 30. doi: 10.1186/s12943-025-02560.
PubMed
Mol Ther
- CHEN Z, Chen X, Xie R, Huang M, et al
DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing
IL-11-STAT3 Signaling and CCND1 Expression.
Mol Ther. 2026 Jan 30:S1525-0016(26)00036-5. doi: 10.1016/j.ymthe.2026.
PubMed
Mol Ther Oncol
- VAN DE MERBEL AF, van der Mark MH, Hensen LCM, van den Wollenberg DJM, et al
Improved oncolytic and immunostimulatory activity of the spontaneous jin-3
reovirus mutant in preclinical bladder cancer models.
Mol Ther Oncol. 2026;34:201128.
PubMed
Abstract available
Nat Rev Urol
- RAGGI D, Crupi E, Pederzoli F, Martini A, et al
HER2 and urothelial carcinoma: current understanding and future directions.
Nat Rev Urol. 2026;23:110-132.
PubMed
Abstract available
- WU K, Liu X, Zhang J, Wang X, et al
Mechanisms and implications of epithelial cell plasticity in the bladder.
Nat Rev Urol. 2026;23:70-88.
PubMed
Abstract available
- DAY E, Bizzarri FP, Mackenzie C, Szabados B, et al
Management of surgical menopause in female patients with bladder cancer
undergoing radical cystectomy.
Nat Rev Urol. 2026 Jan 30. doi: 10.1038/s41585-026-01124.
PubMed
Abstract available
Oncogene
- WANG J, Wang J, Meng L, Wang X, et al
Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by
participating in CUL7-mediated degradation of P53 in bladder cancer.
Oncogene. 2026 Feb 5. doi: 10.1038/s41388-026-03688.
PubMed
Abstract available
Oncol Res Treat
- HILSER T, Darr C, Bedke J, Ivanyi P, et al
Treatment of Advanced or Metastatic Urothelial Cancer.
Oncol Res Treat. 2026;49.
PubMed
Abstract available
Oncology
- CHEN J, Fu S, Yu J, Tang Q, et al
Modified Glasgow prognostic score as a marker for predicting outcomes in patients
with either bladder and prostate cancer : A systematic review and meta-analysis.
Oncology. 2025 Mar 28:1-20. doi: 10.1159/000545001.
PubMed
Abstract available
- TAKADA H, Ikeda M, Tanaka R, Samejima N, et al
Prognostic effect of preoperative albumin-to-globulin ratio in patients with
non-metastatic bladder cancer undergoing radical cystectomy.
Oncology. 2026 Feb 6:1-20. doi: 10.1159/000550892.
PubMed
Abstract available
Pan Afr Med J
- EL OMRI G, Houssaini OI, Rachid M, Houry Y, et al
Non-functional bladder paraganglioma in a young patient: conservative management
by transurethral resection and diagnostic challenges.
Pan Afr Med J. 2025;52:105.
PubMed
Abstract available
Photodiagnosis Photodyn Ther
- KATSUMATA Y, Yamamoto S, Iwata H, Kuroiwa H, et al
Agent-specific differences in sustained intraoperative hypotension during oral
5-Aminolevulinic acid-guided transurethral resection of bladder tumor: A
retrospective observational study.
Photodiagnosis Photodyn Ther. 2026;57:105319.
PubMed
Abstract available
- YAMAMOTO S, Fukata S, Shimasaki S, Kurano Y, et al
Clinical Outcomes Following Transurethral Laser Ablation with Topical Versus
General or Spinal Anesthesia for Non-Muscle-Invasive Bladder Cancer: A Japanese
Single-Center Pilot Study.
Photodiagnosis Photodyn Ther. 2026 Jan 31:105376.
PubMed
Abstract available
PLoS One
- FENG C, Chen G, Shu Y, Chen J, et al
Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3
axis: From computational analysis to experimental validation.
PLoS One. 2026;21:e0342162.
PubMed
Abstract available
Radiol Case Rep
- YOUSSEF M, Nasseredine B, Amine Z, Amine S, et al
Psoas metastasis mimicking abscess in untreated muscle-invasive bladder cancer: A
diagnostic pitfall.
Radiol Case Rep. 2026;21:1554-1558.
PubMed
Abstract available
Research (Wash D C)
- LIU Z, Zhou C, Xu W, Zhang D, et al
Polyarginine Peptide R11-Actin Interaction Induces a Domino Effect on
Cytoskeleton Remodeling to Suppress Bladder Cancer Metastasis.
Research (Wash D C). 2026;9:1109.
PubMed
Abstract available
Sci Rep
- ZARZYCKA M, Kotula-Balak M, Gil D
Inhibiting autophagy enhances anti-cancer properties of sulforaphane.
Sci Rep. 2026;16:5296.
PubMed
Abstract available
- TANG X, Liu L, Gao M, Duan P, et al
Single-cell transcriptomics identifies fibroblast associated immune heterogeneity
and prognostic signatures in bladder cancer.
Sci Rep. 2026 Feb 3. doi: 10.1038/s41598-026-38219.
PubMed
Support Care Cancer
- ZHANG M, Zhou Y
Sexual distress in patients after radical cystectomy for bladder cancer: a
qualitative study.
Support Care Cancer. 2026;34:151.
PubMed
Abstract available
Tissue Cell
- NIHARIKA, Tripathi S, Singhai A, Goel A, et al
Clinical correlates of key autophagic markers, ATG4B, LC3 and p62 in urothelial
carcinoma of bladder patients.
Tissue Cell. 2026;99:103240.
PubMed
Abstract available
Transl Oncol
- LABROY M, Chabaud S, Durand M, Fourquaux I, et al
Improving photodynamic therapy efficacy in bladder cancer using polymer
micelle-encapsulated pheophorbide a.
Transl Oncol. 2026;65:102687.
PubMed
Abstract available
Tumour Virus Res
- LI D, Lu J, Zhu R, Sun X, et al
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent
AMPK-Raptor activation and G2/M arrest.
Tumour Virus Res. 2026;21:200337.
PubMed
Abstract available
Turk J Pediatr
- OZTURK YUZDEMIR K, User IR, Ozcan HN, Orhan D, et al
Pediatric inflammatory myofibroblastic tumor of the urinary bladder: a rare case
report and treatment approach.
Turk J Pediatr. 2025;67:920-926.
PubMed
Abstract available
Urologie
- BOLENZ C, Zengerling F, Kubler H, Hahn O, et al
[Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may
the urinary bladder be preserved?].
Urologie. 2026 Feb 6. doi: 10.1007/s00120-026-02774.
PubMed
Abstract available
Urology
- SIGUENCIA F, Heard J, Smith SM, Pagano I, et al
Diagnostic performance of urinary biomarker tests in detecting bladder cancer: A
systematic review, meta-analysis, and network meta-analysis.
Urology. 2026 Feb 4:S0090-4295(26)00074-9. doi: 10.1016/j.urology.2026.
PubMed
Abstract available
FAQ
